| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744981 | Clinical Microbiology and Infection | 2017 | 17 Pages |
Abstract
Surveillance of asymptomatic patients receiving prophylaxis with micafungin using sGM is unnecessary, because the results are either negative or false-positive. However, sGM remains useful in the diagnosis of breakthrough IA in symptomatic patients during prophylaxis.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
A. Vena, E. Bouza, A. Álvarez-UrÃa, J. Gayoso, P. MartÃn-Rabadán, F. Cajuste, J. Guinea, J. Gómez Castellá, R. Alonso, P. Munoz,